Impact of multiple lymphatic channel drainage to a single nodal basin on outcomes in melanoma

Archives of Surgery

Volumn 142, Issue 8, 2007, Pages 753-756

  Wall, James K ^a   Florero, Marilyn ^a   Accortt, Neil A ^b   Allen, Robert ^a   Kashani Sabet, Mohamed ^a   Morita, Eugene ^a   Leong, Stanley P L ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INVASION; CHILD; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LYMPHADENECTOMY; LYMPHATIC DRAINAGE; MALE; MELANOMA; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SENTINEL LYMPH NODE; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; LOWER EXTREMITY; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MALE; MELANOMA; MIDDLE AGED; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL RATE; THORAX; TREATMENT OUTCOME; UPPER EXTREMITY;

EID: 34548062329     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.142.8.753     Document Type: Article

References (30)

1. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127(4):392-399.
2. Leong SP. Sentinel lymph node mapping and selective lymphadenectomy: the standard of care for melanoma. Curr Treat Options Oncol. 2004;5(3):185-194.
3. Giuliano AE. Sentinel node biopsy: standard of care. Breast J. 2003;9(1):S3-S6.
4. Edge SB, Niland JC, Bookman MA, et al. Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers. J Natl Cancer Inst. 2003;95(20):1514-1521.
5. Singh-Ranger G, Mokbel K. The sentinel node biopsy is a new standard of care for patients with early breast cancer. Int J Fertil Womens Med. 2004;49(5):225-227.
6. Hubalewska-Dydejczyk A, Sowa-Staszczak A, Huszno B. Current application of sentinel lymph node lymphoscintigraphy to detect various cancer metastases. Hell J Nucl Med. 2006;9(1):5-9.
7. Leong SP, Kitagawa Y, Kitajima M, eds. Selective Sentinel Lymphadenectomy for Human Solid Cancer. New York, NY: Springer Verlag; 2005. Cancer Treatment and Research series.
8. Thompson JF, Uren RF. Lymphatic mapping in management of patients with primary cutaneous melanoma. Lancet Oncol. 2005;6(11):877-885.
9. Uren RF, Howman-Giles RB, Chung D, Thompson JF. Role of lymphoscintigraphy for selective sentinel lymphadenectomy. Cancer Treat Res. 2005;127:15-38.
10. Uren RF, Thompson JF, Howman-Giles R, Chung DK. The role of lymphoscintigraphy in the detection of lymph node drainage in melanoma. Surg Oncol Clin N Am. 2006;15(2):285-300.
11. de Wilt JH, Thompson JF, Uren RF, et al. Correlation between preoperative lymphoscintigraphy and metastatic nodal disease sites in 362 patients with cutaneous melanomas of the head and neck. Ann Surg. 2004;239(4):544-552.
12. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17(3):976-983.
13. Chagpar AB, Kehdy F, Scoggins CR, et al. Effect of lymphoscintigraphy drainage patterns on sentinel lymph node biopsy in patients with breast cancer. Am J Surg. 2005;190(4):557-562.
14. Leong SP, Morita ET, Sudmeyer M, et al. Heterogeneous patterns of lymphatic drainage to sentinel lymph nodes by primary melanoma from different anatomic sites. Clin Nucl Med. 2005;30(3):150-158.
15. Nguyen BD, Roarke MC. Triple nodal basin drainage from a clavicular site of melanoma. Clin Nucl Med. 2005;30(11):730-731.
16. McMasters KM. Predicting survival in melanoma. Ann Surg Oncol. 2002;9(2):113-114.
17. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19(16):3622-3634.
18. Wagner JD, Ranieri J, Evdokimow DZ, et al. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma. Plast Reconstr Surg. 2003;112(2):486-497.
19. Balch CM, Buzaid AC, Atkins MB, et al. A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer. 2000;88(6):1484-1491.
20. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19(16):3635-3648.
21. Balch CM, Soong S, Ross MI, et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm): Intergroup Melanoma Surgical Trial. Ann Surg Oncol. 2000;7(2):87-97.
22. Hoshida T, Isaka N, Hagendoorn J, et al. Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res. 2006;66(16):8065-8075.
23. McMasters KM. Multiple nodal basin drainage in truncal melanomas. Ann Surg Oncol. 2000;7(4):249-250.
24. Jacobs IA, Chang CK, Salti GI. Significance of dual-basin drainage in patients with truncal melanoma undergoing sentinel lymph node biopsy. J Am Acad Dermatol. 2003;49(4):615-619.
25. Jimenez RE, Panageas K, Busam KJ, Brady MS. Prognostic implications of multiple lymphatic basin drainage in patients with truncal melanoma. J Clin Oncol. 2005;23(3):518-524.
26. Leong SP, Steinmetz I, Habib FA, et al. Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch Surg. 1997;132(6):666-673.
27. Leong SP. Paradigm of metastasis for melanoma and breast cancer based on the sentinel lymph node experience. Ann Surg Onc. 2004;11(3)(suppl):192s- 197s.
28. Leong SP, Kashani-Sabet M, Desmond RA, et al. Clinical significance of occult metastatic melanoma in sentinel lymph nodes and other high-risk factors based on long-term follow-up. World J Surg. 2005;29(6):683-691.
29. Arnesson LG, Smeds S, Fagerberg G. Recurrence-free survival in patients with small breast cancer: an analysis of cancers 10mmor less detected clinically and by screening. Eur J Surg. 1994;160(5):271-276.
30. Wood WC, Anderson M, Lyles RH, et al. Can we select which patients with small breast cancers should receive adjuvant chemotherapy? Ann Surg. 2002;235(6):859-862.